Target intelligence / Profile preview

Chromosome 1 open reading frame 226 (C1orf226)

Target
C1orf226
Molecular classification
Other (protein-coding, uncharacterized protein)
01

Overview

Chromosome 1 open reading frame 226 (C1orf226) encodes a protein of currently unknown function and is classified as an uncharacterized protein-coding gene. It is mapped to human chromosome 1 and has two known protein-coding transcript variants. C1orf226 has been associated, through genomic studies, with rare disease contexts, including phosphoglycerate dehydrogenase deficiency and nephrotic syndrome, but evidence for a direct causal role remains limited. In neurological studies, it is among a small group of genes whose regulation appears modified in response to TDP-43 knockdown, suggesting indirect or downstream roles in neurodegenerative conditions such as amyotrophic lateral sclerosis, though no direct function or therapeutic relevance has been established. There are no data supporting its classification as a therapeutic target, receptor, or enzyme. Currently, C1orf226 remains a gene of unknown function, requiring further research for full biological and clinical characterization.

Other names
FLJ13137CA226 proteinUncharacterized protein C1orf226C1orf226 homolog (noted for chromosome 3 homolog)
02

Biological functions

Other (function uncharacterized)Possible involvement in brain/neurodevelopmental pathways based on co-regulation and genomic context
03

Disease associations

OtherHas an association with Phosphoglycerate dehydrogenase deficiencyPossible role in monogenic nephrotic syndrome via intergenic fusion with NOS1AP

Beyond the preview

Go deeper on Chromosome 1 open reading frame 226 (C1orf226).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 1 open reading frame 226 (C1orf226).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call